Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncogene Proteins, Fusion | 6 | 2022 | 236 | 2.310 |
Why?
|
| RNA | 8 | 2022 | 517 | 2.220 |
Why?
|
| Gene Fusion | 4 | 2022 | 58 | 1.360 |
Why?
|
| 5' Untranslated Regions | 1 | 2024 | 58 | 0.800 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 38 | 0.700 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 125 | 0.690 |
Why?
|
| RNA, Catalytic | 4 | 2007 | 14 | 0.690 |
Why?
|
| Gene Expression Regulation | 4 | 2024 | 2323 | 0.670 |
Why?
|
| Ovarian Neoplasms | 2 | 2015 | 420 | 0.650 |
Why?
|
| Endometrial Neoplasms | 1 | 2021 | 110 | 0.640 |
Why?
|
| Microtubule Proteins | 1 | 2018 | 28 | 0.570 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 680 | 0.520 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 2026 | 0.500 |
Why?
|
| RNA, Messenger | 6 | 2020 | 2550 | 0.470 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 889 | 0.440 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2015 | 50 | 0.430 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 41 | 0.430 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2014 | 5 | 0.420 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 710 | 0.410 |
Why?
|
| N-Terminal Acetyltransferase C | 1 | 2013 | 2 | 0.410 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 1939 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 480 | 0.360 |
Why?
|
| Transcription Factors | 1 | 2021 | 2406 | 0.360 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2026 | 66 | 0.340 |
Why?
|
| Transfection | 3 | 2021 | 962 | 0.340 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 588 | 0.330 |
Why?
|
| Transcriptional Regulator ERG | 2 | 2022 | 40 | 0.320 |
Why?
|
| Alternative Splicing | 3 | 2024 | 307 | 0.320 |
Why?
|
| Cell Line | 7 | 2020 | 2552 | 0.300 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 388 | 0.290 |
Why?
|
| Biomarkers, Tumor | 2 | 2014 | 1586 | 0.280 |
Why?
|
| Protein Biosynthesis | 2 | 2026 | 569 | 0.280 |
Why?
|
| Oncogene Fusion | 2 | 2022 | 25 | 0.280 |
Why?
|
| Biological Assay | 1 | 2009 | 105 | 0.280 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 750 | 0.270 |
Why?
|
| Small Molecule Libraries | 1 | 2009 | 129 | 0.260 |
Why?
|
| Genetic Engineering | 2 | 2007 | 161 | 0.260 |
Why?
|
| Base Sequence | 5 | 2015 | 2730 | 0.240 |
Why?
|
| Eye Proteins | 2 | 2018 | 221 | 0.240 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2026 | 9 | 0.230 |
Why?
|
| RNA, Small Nucleolar | 1 | 2026 | 15 | 0.230 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1590 | 0.230 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1692 | 0.230 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2026 | 90 | 0.230 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 242 | 0.220 |
Why?
|
| Poly A | 1 | 2024 | 45 | 0.200 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 274 | 0.200 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 3748 | 0.200 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 573 | 0.190 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1419 | 0.190 |
Why?
|
| Transgenes | 1 | 2024 | 316 | 0.190 |
Why?
|
| Translocation, Genetic | 2 | 2015 | 344 | 0.190 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2001 | 124 | 0.180 |
Why?
|
| RNA-Binding Proteins | 1 | 2026 | 533 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 253 | 0.160 |
Why?
|
| Humans | 18 | 2026 | 131163 | 0.160 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 3464 | 0.160 |
Why?
|
| Endoribonucleases | 1 | 2001 | 87 | 0.160 |
Why?
|
| Genomic Instability | 1 | 2021 | 245 | 0.160 |
Why?
|
| N-Methylaspartate | 2 | 2001 | 29 | 0.150 |
Why?
|
| Stromal Cells | 1 | 2021 | 316 | 0.150 |
Why?
|
| Animals | 10 | 2026 | 33912 | 0.150 |
Why?
|
| Chromosome Breakpoints | 1 | 2020 | 81 | 0.150 |
Why?
|
| Progesterone | 1 | 2021 | 439 | 0.150 |
Why?
|
| DNA, Single-Stranded | 1 | 1999 | 69 | 0.150 |
Why?
|
| Estrogens | 1 | 2021 | 434 | 0.150 |
Why?
|
| Computational Biology | 2 | 2016 | 862 | 0.140 |
Why?
|
| Endometrium | 1 | 2021 | 292 | 0.140 |
Why?
|
| Huntington Disease | 1 | 1999 | 126 | 0.140 |
Why?
|
| SELEX Aptamer Technique | 2 | 2016 | 5 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2018 | 26 | 0.140 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2018 | 32 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 743 | 0.130 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 197 | 0.130 |
Why?
|
| Genome, Human | 2 | 2021 | 1321 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 258 | 0.130 |
Why?
|
| Chromosome Mapping | 1 | 2020 | 1046 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 1801 | 0.130 |
Why?
|
| Polyps | 1 | 2017 | 38 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 1447 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2009 | 341 | 0.120 |
Why?
|
| Toyocamycin | 2 | 2006 | 2 | 0.110 |
Why?
|
| Superior Colliculi | 1 | 1995 | 13 | 0.110 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 118 | 0.110 |
Why?
|
| Adenosine | 2 | 2006 | 116 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 450 | 0.100 |
Why?
|
| Mice | 4 | 2024 | 18301 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 1995 | 96 | 0.100 |
Why?
|
| Neurons | 2 | 2020 | 1979 | 0.100 |
Why?
|
| In Situ Hybridization | 2 | 2013 | 437 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2015 | 576 | 0.100 |
Why?
|
| Chimerism | 1 | 2013 | 29 | 0.100 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 66 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2020 | 889 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2013 | 5063 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 323 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2015 | 450 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2013 | 80 | 0.090 |
Why?
|
| Axons | 1 | 1995 | 386 | 0.090 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 317 | 0.090 |
Why?
|
| Synapses | 1 | 1995 | 425 | 0.090 |
Why?
|
| Clone Cells | 2 | 2009 | 153 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2015 | 1571 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2395 | 0.080 |
Why?
|
| Proteins | 1 | 2016 | 1006 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 621 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 373 | 0.080 |
Why?
|
| Prostatectomy | 1 | 2011 | 304 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 722 | 0.080 |
Why?
|
| Female | 4 | 2021 | 70963 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2004 | 892 | 0.070 |
Why?
|
| Databases, Genetic | 1 | 2011 | 504 | 0.070 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 70 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1545 | 0.070 |
Why?
|
| Schistosoma mansoni | 1 | 2007 | 25 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2010 | 483 | 0.060 |
Why?
|
| Transcriptome | 1 | 2013 | 1103 | 0.060 |
Why?
|
| Tubercidin | 1 | 2006 | 2 | 0.060 |
Why?
|
| Acridine Orange | 1 | 2006 | 3 | 0.060 |
Why?
|
| Ethidium | 1 | 2006 | 5 | 0.060 |
Why?
|
| Cytidine | 1 | 2006 | 13 | 0.060 |
Why?
|
| Uridine | 1 | 2006 | 31 | 0.060 |
Why?
|
| Guanine | 1 | 2006 | 58 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 135 | 0.060 |
Why?
|
| Cell Nucleolus | 1 | 2026 | 48 | 0.060 |
Why?
|
| RNA, Ribosomal | 1 | 2026 | 48 | 0.060 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 149 | 0.060 |
Why?
|
| Fluorouracil | 1 | 2006 | 130 | 0.060 |
Why?
|
| RNA Stability | 1 | 2026 | 77 | 0.060 |
Why?
|
| Exosomes | 1 | 2026 | 60 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 123 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 315 | 0.060 |
Why?
|
| Base Pairing | 1 | 2004 | 40 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2006 | 700 | 0.050 |
Why?
|
| Catalysis | 1 | 2004 | 136 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2026 | 686 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2004 | 94 | 0.050 |
Why?
|
| Cricetinae | 1 | 2004 | 362 | 0.050 |
Why?
|
| Prognosis | 1 | 2013 | 4886 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2004 | 394 | 0.050 |
Why?
|
| Mutation | 2 | 2014 | 6099 | 0.050 |
Why?
|
| Exons | 2 | 2010 | 759 | 0.050 |
Why?
|
| Gene Expression | 2 | 2018 | 1481 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 2904 | 0.040 |
Why?
|
| Ribonuclease T1 | 1 | 2001 | 1 | 0.040 |
Why?
|
| Ribonuclease P | 1 | 2001 | 9 | 0.040 |
Why?
|
| RNA, Small Untranslated | 1 | 2001 | 20 | 0.040 |
Why?
|
| RNA Editing | 1 | 2001 | 31 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2001 | 121 | 0.040 |
Why?
|
| Simplexvirus | 1 | 2001 | 100 | 0.040 |
Why?
|
| DNA, Catalytic | 1 | 1999 | 3 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 1999 | 83 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2001 | 403 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 150 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 133 | 0.040 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2018 | 22 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2001 | 445 | 0.030 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 57 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2018 | 242 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 1207 | 0.030 |
Why?
|
| Astrocytes | 1 | 2020 | 264 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 192 | 0.030 |
Why?
|
| Rats | 2 | 2001 | 3370 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 65 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2018 | 286 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 254 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 109 | 0.030 |
Why?
|
| Male | 2 | 2013 | 64957 | 0.030 |
Why?
|
| Metamorphosis, Biological | 1 | 1995 | 6 | 0.030 |
Why?
|
| Horseradish Peroxidase | 1 | 1995 | 14 | 0.030 |
Why?
|
| Rana pipiens | 1 | 1995 | 29 | 0.030 |
Why?
|
| Synaptic Membranes | 1 | 1995 | 22 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2885 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 44 | 0.030 |
Why?
|
| Axonal Transport | 1 | 1995 | 24 | 0.030 |
Why?
|
| Aged | 1 | 2013 | 21025 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 305 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 1995 | 141 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 713 | 0.030 |
Why?
|
| Spinal Cord | 1 | 1995 | 255 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 1011 | 0.030 |
Why?
|
| Middle Aged | 1 | 2013 | 28601 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 716 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 972 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2013 | 749 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2465 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 3175 | 0.020 |
Why?
|
| Theophylline | 1 | 2007 | 23 | 0.020 |
Why?
|
| Allosteric Site | 1 | 2007 | 12 | 0.020 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2007 | 14 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2007 | 57 | 0.020 |
Why?
|
| Caffeine | 1 | 2007 | 66 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2007 | 177 | 0.020 |
Why?
|
| Kinetics | 1 | 2007 | 1088 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 1797 | 0.010 |
Why?
|
| Sequence Analysis, RNA | 1 | 2007 | 407 | 0.010 |
Why?
|
| Neoplasms | 1 | 2013 | 3016 | 0.010 |
Why?
|
| Autoradiography | 1 | 1995 | 61 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1995 | 131 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 1105 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1995 | 1021 | 0.010 |
Why?
|